21 CFR 522.533
§ 522.533 Deslorelin.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 522.533, § 522.533 Deslorelin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87415
- Permanent ID
ys:prov:87415@1- SHA-256
c88f7813b3d9e2575bebb60e3e2d5b03d4d9e004b0d0d68f402f76e5a645a96b
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications.
(1) Each implant contains 2.1 milligrams (mg) deslorelin acetate.
(2) [Reserved]
(b) Sponsors. See sponsor numbers in § 510.600(c) of this chapter as follows:
(1) No. 051311 for use of product described in paragraph (a)(1) as in paragraph (c)(1) of this section.
(2) [Reserved]
(c) Conditions of use—(1) Horses and ponies—(i) Amount. One implant per mare subcutaneously in the neck.
(ii) Indications for use. For inducing ovulation within 48 hours in estrous mares with an ovarian follicle greater than 30 millimeters (mm) in diameter.
(iii) Limitations. Do not use in horses or ponies intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
(2) [Reserved]
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.